The Future of Infectious Disease Treatments

Combating antimicrobial resistance with breakthrough rapid testing technology that delivers results 40–60 hours faster, saving lives and reducing healthcare costs.

Learn About GIANT

About GIANT BioSystems

GIANT BioSystems is a pioneering medtech company founded in 2023, dedicated to revolutionizing antimicrobial susceptibility testing (AST). Our mission is to address the global crisis of antimicrobial resistance (AMR) by providing healthcare professionals with rapid, accurate, and comprehensive antibiotic testing solutions.

Through innovative technology, we enable clinicians to make informed treatment decisions faster, improving patient outcomes and reducing the burden on healthcare systems worldwide.

Learn More

The Impact of Antimicrobial Resistance

1.27M

Deaths Annually

Attributed directly to antimicrobial resistance worldwide

40-60

Hours Faster

GIANT delivers AST results compared to traditional methods

$4.6B

Annual Cost

Additional healthcare costs in the US alone due to AMR

50+

Antibiotics Tested

Comprehensive testing capability in a single GIANT assay

Ready to Transform Infectious Disease Treatment?

Discover how GIANT BioSystems is revolutionizing antimicrobial susceptibility testing.

Get in Touch